TY - JOUR
T1 - Cancer chemoprevention
T2 - A new way to treat cancer before it happens
AU - Krishnan, K.
AU - Ruffin IV, M. T.
AU - Brenner, D. E.
N1 - Funding Information:
The study was supported by Department of Veterans Affairs, VA Merit Review, American Cancer Society Grant EDT-55, National Cancer Institute CN-25429, and the University of Michigan Cancer Center Munn Fund.
PY - 1998
Y1 - 1998
N2 - Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.
AB - Cancer chemoprevention uses noncytotoxic drugs or nutrients to prevent, retard, or delay carcinogenesis. The future of cancer chemoprevention depends on understanding key cellular growth and proliferation-controlling events, developing markers of molecular carcinogenesis, surrogate endpoint biomarkers, and targeted chemopreventive approaches.
UR - http://www.scopus.com/inward/record.url?scp=0031832577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031832577&partnerID=8YFLogxK
U2 - 10.1016/S0095-4543(05)70069-5
DO - 10.1016/S0095-4543(05)70069-5
M3 - Article
C2 - 9628956
AN - SCOPUS:0031832577
VL - 25
SP - 361
EP - 379
JO - Primary Care - Clinics in Office Practice
JF - Primary Care - Clinics in Office Practice
SN - 0095-4543
IS - 2
ER -